Skip to main navigation
Scientists Patients Medical Professionals Investors and Media Careers
 logo
  • News
  • Events
  • Stock
  • Financials
  • Governance
  • FAQs
    • Scientists
    • Patients
    • Medical Professionals
    • Investors and Media
    • Careers

INVESTORS & MEDIA

Event

Events & Presentations
Archived Presentations

American Society of Hematology (ASH) 2019 Annual Meeting

Dec 82019 Dec 8, 2019

Supporting Materials

Phase 1 of REGN5458 (BCMAxCD3) in Relapsed/Refractory Multiple Myeloma 359.1 KB
Phase 1 of Pozelimab (REGN3918) in Normal Healthy Volunteers 415.8 KB
Study Design: Phase 2 of REGN1979 (CD3xCD20) in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (B-NHL) 148.4 KB
REGN1979 in patients with R/R B-NHL – ASH 2019 data update 991.9 KB
Email Alerts
RSS Newsfeed
Share This Page
Search
Regeneron logo
  • Twitter logo
  • LinkedIn logo
  • Facebook logo
  • Instagram logo
  • YouTube logo
  • Terms of Use
  • Contact Us
  • Site Map
  • Social Media Terms of Engagement
  • Privacy Notice
  • Accessibility Statement
  • Investors and Media
  • Careers
  • Ireland
  • Covid-19 Antibody Program

Copyright © 2023 Regeneron Pharmaceuticals Inc. All rights reserved. All trademarks mentioned are the property of their respective owners.

Back to top

Investors & Media

  • Facebook
  • LinkedIn
  • Twitter
  • RSS Feeds

You are now leaving Regeneron.com. The site you are about to visit is maintained by a third party who is solely responsible for its content. We encourage you to read the privacy policy of every website you visit.

Continue

You are now leaving Regeneron.com to visit another Regeneron pharmaceuticals website.

Continue